Faster Please: Alnylam, Eiger & BioCryst Want Quick EMA Reviews

 
• By Neena Brizmohun

Three companies are set to learn this week whether the European Medicines Agency will fast track its review of their soon-to-be-filed EU marketing applications.

Hand_Turning_Button_Rocket
The EMA has a pathway for reviewing marketing applications faster • Source: Shutterstock

More from Europe

More from Geography